Clinical Trials Directory

Trials / Completed

CompletedNCT04884087

EMA of Substance Use in Homeless Youth

Ecological Momentary Assessment of Substance Use in Homeless Youth

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
All
Age
18 Years – 24 Years
Healthy volunteers
Not accepted

Summary

The proposed study will provide critical information on Ecological Momentary Assessment (EMA) design characteristics that promote retention in a vulnerable and under-represented population in research-youth experiencing homelessness. The study will use an EMA app to collect substance use, mood, craving, social surroundings, and trauma measures over a 14-day period in youth age 18-24 (n=40) recruited from Star House, a homeless youth drop-in center. Youth will be randomized in 2x2 factorial design (fixed incentive model vs. prize-based model; random assessment 3x vs. 6x per day).

Conditions

Interventions

TypeNameDescription
BEHAVIORALEcological Momentary Assessment (EMA; Metricwire) Prompts 3x/dayParticipants receive 3 EMA survey prompts daily for the duration of the study.
BEHAVIORALEcological Momentary Assessment (EMA; Metricwire) Prompts 6x/dayParticipants receive 6 EMA survey prompts daily for the duration of the study.
BEHAVIORALIncentive Structure - fixedThose assigned to the "fixed" incentive condition will earn a fixed bonus based on EMA completion (50-74%=$3; 75-89%=$5; ≥90%=$10) each week.
BEHAVIORALIncentive Structure - prize basedThose assigned to the "prize-based" incentive will be rewarded for high survey completion with increasing numbers of "draws" depending on their level of response to EMA prompts each week (50-74%=1 draw, 75-89%=2 draws, ≥90%=3 draws). For each draw, individuals will use the EMA app to "spin the wheel" to see which prize amount they earn. Out of a total of 500 total draws, 50% will be $1, 43.6% will be $3, 6% will be medium prizes ($5), and 0.4% will be a "jumbo" prize ($90).

Timeline

Start date
2021-02-24
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2021-05-12
Last updated
2023-03-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04884087. Inclusion in this directory is not an endorsement.